In addition to APOE’s involvement in lipid metabolism, APOE4 is associated with hypertension (40) and obesity (41), both of which are risk factors for CVD and T2DM (42,43). This evidence concerns the gene APOE and obesity due to melanocortin 4 receptor deficiency.